{"pmid":32492144,"title":"The case for why Africa should host COVID-19 candidate vaccine trials.","text":["The case for why Africa should host COVID-19 candidate vaccine trials.","In response to provocative comments by two European clinicians and scientists, the WHO Director General has declared that Africa will not host COVID-19 vaccine trials. Such a stance risks stigmatising COVID-19 vaccine trials in Africa and depriving Africa of critical research. To the contrary, there is a critical need for Africa to host COVID-19 vaccine trials on public health, scientific, and ethics grounds.","J Infect Dis","Singh, Jerome Amir","32492144"],"abstract":["In response to provocative comments by two European clinicians and scientists, the WHO Director General has declared that Africa will not host COVID-19 vaccine trials. Such a stance risks stigmatising COVID-19 vaccine trials in Africa and depriving Africa of critical research. To the contrary, there is a critical need for Africa to host COVID-19 vaccine trials on public health, scientific, and ethics grounds."],"journal":"J Infect Dis","authors":["Singh, Jerome Amir"],"date":"2020-06-04T11:00:00Z","year":2020,"_id":"32492144","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1093/infdis/jiaa303","weight":0,"_version_":1668892169271771136,"score":9.490897,"similar":[{"pmid":32288543,"pmcid":"PMC7146014","title":"Is Sub-Saharan Africa prepared for COVID-19?","text":["Is Sub-Saharan Africa prepared for COVID-19?","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), is the latest virus to cause global health panic. Due to the rapidly escalating numbers of new infections outside China, COVID-19 was declared a pandemic by the World Health Organization (WHO) on March 11, 2020, in a message delivered by Dr. Tedros Adhanom Ghebreyesus, the WHO Director-General [1]. As of March 21, about 166 countries globally had recoded cases of the COVID-19 in only 4 months since its outbreak in Wuhan, Hubei Province, China [2, 3]. With the Antarctic continent unaffected, Africa, in particular Sub-Saharan Africa (SSA), has recorded the least number of cases, despite the cited moderate-to-high risk of infection [4]. The biggest challenge is whether Sub-Saharan Africa is ready for this pandemic.","Trop Med Health","Nuwagira, Edwin","Muzoora, Conrad","32288543"],"abstract":["Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), is the latest virus to cause global health panic. Due to the rapidly escalating numbers of new infections outside China, COVID-19 was declared a pandemic by the World Health Organization (WHO) on March 11, 2020, in a message delivered by Dr. Tedros Adhanom Ghebreyesus, the WHO Director-General [1]. As of March 21, about 166 countries globally had recoded cases of the COVID-19 in only 4 months since its outbreak in Wuhan, Hubei Province, China [2, 3]. With the Antarctic continent unaffected, Africa, in particular Sub-Saharan Africa (SSA), has recorded the least number of cases, despite the cited moderate-to-high risk of infection [4]. The biggest challenge is whether Sub-Saharan Africa is ready for this pandemic."],"journal":"Trop Med Health","authors":["Nuwagira, Edwin","Muzoora, Conrad"],"date":"2020-04-15T11:00:00Z","year":2020,"_id":"32288543","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1186/s41182-020-00206-x","keywords":["covid-19","sub-saharan africa"],"locations":["China","Wuhan","Hubei","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1666138491296153600,"score":126.22853},{"pmid":32387041,"title":"COVID-19 and Moral Imperialism in Multinational Clinical Research.","text":["COVID-19 and Moral Imperialism in Multinational Clinical Research.","A TV debate in April 2020 between two French doctors regarding the benefits of testing a coronavirus vaccine in Africa where there are no masks or treatments available has led to international criticism. This case highlights a problematic ethical double standard in multinational clinical research: trials that would be considered unethical in high income countries (e.g., placebo-controlled where there is an existing treatment) are nonetheless justified in low-and-middle-income countries because the existing standards of care are less (i.e., no access to a treatment). Underlying this ethical double standard in some multinational clinical trials is a moral imperialism and persistent colonialist thinking that must be rejected.","Arch Med Res","Hellmann, Fernando","Williams-Jones, Bryn","Garrafa, Volnei","32387041"],"abstract":["A TV debate in April 2020 between two French doctors regarding the benefits of testing a coronavirus vaccine in Africa where there are no masks or treatments available has led to international criticism. This case highlights a problematic ethical double standard in multinational clinical research: trials that would be considered unethical in high income countries (e.g., placebo-controlled where there is an existing treatment) are nonetheless justified in low-and-middle-income countries because the existing standards of care are less (i.e., no access to a treatment). Underlying this ethical double standard in some multinational clinical trials is a moral imperialism and persistent colonialist thinking that must be rejected."],"journal":"Arch Med Res","authors":["Hellmann, Fernando","Williams-Jones, Bryn","Garrafa, Volnei"],"date":"2020-05-11T11:00:00Z","year":2020,"_id":"32387041","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.arcmed.2020.04.017","keywords":["covid-19","clinical trials","colonialism","ethics","low-and-middle-income countries","research design"],"locations":["French"],"countries":["France"],"countries_codes":["FRA|France"],"weight":0,"_version_":1666428892744777729,"score":111.43854},{"pmid":32323646,"title":"Chloroquine and Hydroxychloroquine for the Prevention or Treatment of Novel Coronavirus Disease (COVID-19) in Africa: Caution for Inappropriate Off-Label Use in Healthcare Settings.","text":["Chloroquine and Hydroxychloroquine for the Prevention or Treatment of Novel Coronavirus Disease (COVID-19) in Africa: Caution for Inappropriate Off-Label Use in Healthcare Settings.","The novel severe acute respiratory syndrome-coronavirus-2 pandemic has spread to Africa, where nearly all countries have reported laboratory-confirmed cases of novel coronavirus disease (COVID-19). Although there are ongoing clinical trials of repurposed and investigational antiviral and immune-based therapies, there are as yet no scientifically proven, clinically effective pharmacological treatments for COVID-19. Among the repurposed drugs, the commonly used antimalarials chloroquine (CQ) and hydroxychloroquine (HCQ) have become the focus of global scientific, media, and political attention despite a lack of randomized clinical trials supporting their efficacy. Chloroquine has been used worldwide for about 75 years and is listed by the WHO as an essential medicine to treat malaria. Hydroxychloroquine is mainly used as a therapy for autoimmune diseases. However, the efficacy and safety of CQ/HCQ for the treatment of COVID-19 remains to be defined. Indiscriminate promotion and widespread use of CQ/HCQ have led to extensive shortages, self-treatment, and fatal overdoses. Shortages and increased market prices leave all countries vulnerable to substandard and falsified medical products, and safety issues are especially concerning for Africa because of its healthcare system limitations. Much needed in Africa is a cross-continental collaborative network for coordinated production, distribution, and post-marketing surveillance aligned to low-cost distribution of any approved COVID-19 drug; this would ideally be piggybacked on existing global aid efforts. Meanwhile, African countries should strongly consider implementing prescription monitoring schemes to ensure that any off-label CQ/HCQ use is appropriate and beneficial during this pandemic.","Am J Trop Med Hyg","Abena, Pascale M","Decloedt, Eric H","Bottieau, Emmanuel","Suleman, Fatima","Adejumo, Prisca","Sam-Agudu, Nadia A","Muyembe TamFum, Jean-Jacques","Seydi, Moussa","Eholie, Serge P","Mills, Edward J","Kallay, Oscar","Zumla, Alimuddin","Nachega, Jean B","32323646"],"abstract":["The novel severe acute respiratory syndrome-coronavirus-2 pandemic has spread to Africa, where nearly all countries have reported laboratory-confirmed cases of novel coronavirus disease (COVID-19). Although there are ongoing clinical trials of repurposed and investigational antiviral and immune-based therapies, there are as yet no scientifically proven, clinically effective pharmacological treatments for COVID-19. Among the repurposed drugs, the commonly used antimalarials chloroquine (CQ) and hydroxychloroquine (HCQ) have become the focus of global scientific, media, and political attention despite a lack of randomized clinical trials supporting their efficacy. Chloroquine has been used worldwide for about 75 years and is listed by the WHO as an essential medicine to treat malaria. Hydroxychloroquine is mainly used as a therapy for autoimmune diseases. However, the efficacy and safety of CQ/HCQ for the treatment of COVID-19 remains to be defined. Indiscriminate promotion and widespread use of CQ/HCQ have led to extensive shortages, self-treatment, and fatal overdoses. Shortages and increased market prices leave all countries vulnerable to substandard and falsified medical products, and safety issues are especially concerning for Africa because of its healthcare system limitations. Much needed in Africa is a cross-continental collaborative network for coordinated production, distribution, and post-marketing surveillance aligned to low-cost distribution of any approved COVID-19 drug; this would ideally be piggybacked on existing global aid efforts. Meanwhile, African countries should strongly consider implementing prescription monitoring schemes to ensure that any off-label CQ/HCQ use is appropriate and beneficial during this pandemic."],"journal":"Am J Trop Med Hyg","authors":["Abena, Pascale M","Decloedt, Eric H","Bottieau, Emmanuel","Suleman, Fatima","Adejumo, Prisca","Sam-Agudu, Nadia A","Muyembe TamFum, Jean-Jacques","Seydi, Moussa","Eholie, Serge P","Mills, Edward J","Kallay, Oscar","Zumla, Alimuddin","Nachega, Jean B"],"date":"2020-04-24T11:00:00Z","year":2020,"_id":"32323646","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.4269/ajtmh.20-0290","e_drugs":["Hydroxychloroquine","Chloroquine"],"topics":["Treatment","Prevention"],"weight":1,"_version_":1666138493824270336,"score":108.4724},{"pmid":32414379,"title":"COVID-19 in Africa: care and protection for frontline healthcare workers.","text":["COVID-19 in Africa: care and protection for frontline healthcare workers.","Medical staff caring for COVID-19 patients face mental stress, physical exhaustion, separation from families, stigma, and the pain of losing patients and colleagues. Many of them have acquired SARS-CoV-2 and some have died. In Africa, where the pandemic is escalating, there are major gaps in response capacity, especially in human resources and protective equipment. We examine these challenges and propose interventions to protect healthcare workers on the continent, drawing on articles identified on Medline (Pubmed) in a search on 24 March 2020. Global jostling means that supplies of personal protective equipment are limited in Africa. Even low-cost interventions such as facemasks for patients with a cough and water supplies for handwashing may be challenging, as is 'physical distancing' in overcrowded primary health care clinics. Without adequate protection, COVID-19 mortality may be high among healthcare workers and their family in Africa given limited critical care beds and difficulties in transporting ill healthcare workers from rural to urban care centres. Much can be done to protect healthcare workers, however. The continent has learnt invaluable lessons from Ebola and HIV control. HIV counselors and community healthcare workers are key resources, and could promote social distancing and related interventions, dispel myths, support healthcare workers, perform symptom screening and trace contacts. Staff motivation and retention may be enhanced through carefully managed risk 'allowances' or compensation. International support with personnel and protective equipment, especially from China, could turn the pandemic's trajectory in Africa around. Telemedicine holds promise as it rationalises human resources and reduces patient contact and thus infection risks. Importantly, healthcare workers, using their authoritative voice, can promote effective COVID-19 policies and prioritization of their safety. Prioritizing healthcare workers for SARS-CoV-2 testing, hospital beds and targeted research, as well as ensuring that public figures and the population acknowledge the commitment of healthcare workers may help to maintain morale. Clearly there are multiple ways that international support and national commitment could help safeguard healthcare workers in Africa, essential for limiting the pandemic's potentially devastating heath, socio-economic and security impacts on the continent.","Global Health","Chersich, Matthew F","Gray, Glenda","Fairlie, Lee","Eichbaum, Quentin","Mayhew, Susannah","Allwood, Brian","English, Rene","Scorgie, Fiona","Luchters, Stanley","Simpson, Greg","Haghighi, Marjan Mosalman","Pham, Minh Duc","Rees, Helen","32414379"],"abstract":["Medical staff caring for COVID-19 patients face mental stress, physical exhaustion, separation from families, stigma, and the pain of losing patients and colleagues. Many of them have acquired SARS-CoV-2 and some have died. In Africa, where the pandemic is escalating, there are major gaps in response capacity, especially in human resources and protective equipment. We examine these challenges and propose interventions to protect healthcare workers on the continent, drawing on articles identified on Medline (Pubmed) in a search on 24 March 2020. Global jostling means that supplies of personal protective equipment are limited in Africa. Even low-cost interventions such as facemasks for patients with a cough and water supplies for handwashing may be challenging, as is 'physical distancing' in overcrowded primary health care clinics. Without adequate protection, COVID-19 mortality may be high among healthcare workers and their family in Africa given limited critical care beds and difficulties in transporting ill healthcare workers from rural to urban care centres. Much can be done to protect healthcare workers, however. The continent has learnt invaluable lessons from Ebola and HIV control. HIV counselors and community healthcare workers are key resources, and could promote social distancing and related interventions, dispel myths, support healthcare workers, perform symptom screening and trace contacts. Staff motivation and retention may be enhanced through carefully managed risk 'allowances' or compensation. International support with personnel and protective equipment, especially from China, could turn the pandemic's trajectory in Africa around. Telemedicine holds promise as it rationalises human resources and reduces patient contact and thus infection risks. Importantly, healthcare workers, using their authoritative voice, can promote effective COVID-19 policies and prioritization of their safety. Prioritizing healthcare workers for SARS-CoV-2 testing, hospital beds and targeted research, as well as ensuring that public figures and the population acknowledge the commitment of healthcare workers may help to maintain morale. Clearly there are multiple ways that international support and national commitment could help safeguard healthcare workers in Africa, essential for limiting the pandemic's potentially devastating heath, socio-economic and security impacts on the continent."],"journal":"Global Health","authors":["Chersich, Matthew F","Gray, Glenda","Fairlie, Lee","Eichbaum, Quentin","Mayhew, Susannah","Allwood, Brian","English, Rene","Scorgie, Fiona","Luchters, Stanley","Simpson, Greg","Haghighi, Marjan Mosalman","Pham, Minh Duc","Rees, Helen"],"date":"2020-05-17T11:00:00Z","year":2020,"_id":"32414379","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1186/s12992-020-00574-3","keywords":["africa","covid-19","healthcare workers","human resources for health","infection control, mental health","sars-cov-2"],"locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"e_drugs":["Water"],"topics":["Prevention"],"weight":1,"_version_":1666991242642194432,"score":102.57293},{"pmid":32391440,"pmcid":"PMC7200322","title":"Current efforts and challenges facing responses to 2019-nCoV in Africa.","text":["Current efforts and challenges facing responses to 2019-nCoV in Africa.","The novel coronavirus is a pandemic that has started to creep into Africa thus making the virus a truly global, health security threat. The number of new 2019-nCoV cases has been rising in Africa, though currently lower than the cases reported outside the region. African countries have activated their Emergency Operations Centres to coordinate responses and preparedness activities to the pandemic. A series of measures such as restricting travel, case detection and contact tracing, mandatory quarantine, guidance and information to the public among other efforts are being implemented across Africa. However, the presence of porous borders, the double burden of communicable and non-communicable diseases, poverty, poor health literacy, infodemic and family clustering, and most of all, weak health systems, may make containment challenging. It is important for African countries to continue to intensify efforts and address the challenges to effectively respond to the uncertainty the pandemic poses.","Glob Health Res Policy","Lucero-Prisno, Don Eliseo 3rd","Adebisi, Yusuff Adebayo","Lin, Xu","32391440"],"abstract":["The novel coronavirus is a pandemic that has started to creep into Africa thus making the virus a truly global, health security threat. The number of new 2019-nCoV cases has been rising in Africa, though currently lower than the cases reported outside the region. African countries have activated their Emergency Operations Centres to coordinate responses and preparedness activities to the pandemic. A series of measures such as restricting travel, case detection and contact tracing, mandatory quarantine, guidance and information to the public among other efforts are being implemented across Africa. However, the presence of porous borders, the double burden of communicable and non-communicable diseases, poverty, poor health literacy, infodemic and family clustering, and most of all, weak health systems, may make containment challenging. It is important for African countries to continue to intensify efforts and address the challenges to effectively respond to the uncertainty the pandemic poses."],"journal":"Glob Health Res Policy","authors":["Lucero-Prisno, Don Eliseo 3rd","Adebisi, Yusuff Adebayo","Lin, Xu"],"date":"2020-05-12T11:00:00Z","year":2020,"_id":"32391440","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1186/s41256-020-00148-1","keywords":["2019-ncov","africa","covid-19","coronavirus","global health","outbreak","pandemic","sars-cov-2"],"topics":["Prevention"],"weight":1,"_version_":1666528580136337408,"score":101.59261}]}